Literature DB >> 10508236

Voltage-gated ion channels and hereditary disease.

F Lehmann-Horn1, K Jurkat-Rott.   

Abstract

By the introduction of technological advancement in methods of structural analysis, electronics, and recombinant DNA techniques, research in physiology has become molecular. Additionally, focus of interest has been moving away from classical physiology to become increasingly centered on mechanisms of disease. A wonderful example for this development, as evident by this review, is the field of ion channel research which would not be nearly as advanced had it not been for human diseases to clarify. It is for this reason that structure-function relationships and ion channel electrophysiology cannot be separated from the genetic and clinical description of ion channelopathies. Unique among reviews of this topic is that all known human hereditary diseases of voltage-gated ion channels are described covering various fields of medicine such as neurology (nocturnal frontal lobe epilepsy, benign neonatal convulsions, episodic ataxia, hemiplegic migraine, deafness, stationary night blindness), nephrology (X-linked recessive nephrolithiasis, Bartter), myology (hypokalemic and hyperkalemic periodic paralysis, myotonia congenita, paramyotonia, malignant hyperthermia), cardiology (LQT syndrome), and interesting parallels in mechanisms of disease emphasized. Likewise, all types of voltage-gated ion channels for cations (sodium, calcium, and potassium channels) and anions (chloride channels) are described together with all knowledge about pharmacology, structure, expression, isoforms, and encoding genes.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10508236     DOI: 10.1152/physrev.1999.79.4.1317

Source DB:  PubMed          Journal:  Physiol Rev        ISSN: 0031-9333            Impact factor:   37.312


  126 in total

1.  Role of the C-terminal domain in inactivation of brain and cardiac sodium channels.

Authors:  M Mantegazza; F H Yu; W A Catterall; T Scheuer
Journal:  Proc Natl Acad Sci U S A       Date:  2001-12-11       Impact factor: 11.205

Review 2.  Periodic paralysis: understanding channelopathies.

Authors:  Frank Lehmann-Horn; Karin Jurkat-Rott; Reinhardt Rüdel
Journal:  Curr Neurol Neurosci Rep       Date:  2002-01       Impact factor: 5.081

Review 3.  Skeletal muscle sodium current is reduced in hypokalemic periodic paralysis.

Authors:  R L Ruff
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-29       Impact factor: 11.205

4.  Three-dimensional reconstruction of the recombinant type 3 ryanodine receptor and localization of its amino terminus.

Authors:  Z Liu; J Zhang; M R Sharma; P Li; S R Chen; T Wagenknecht
Journal:  Proc Natl Acad Sci U S A       Date:  2001-05-15       Impact factor: 11.205

Review 5.  The impact of splice isoforms on voltage-gated calcium channel alpha1 subunits.

Authors:  Karin Jurkat-Rott; Frank Lehmann-Horn
Journal:  J Physiol       Date:  2003-11-28       Impact factor: 5.182

6.  Mechanisms of cold sensitivity of paramyotonia congenita mutation R1448H and overlap syndrome mutation M1360V.

Authors:  Bahram Mohammadi; Nenad Mitrovic; Frank Lehmann-Horn; Reinhard Dengler; Johannes Bufler
Journal:  J Physiol       Date:  2003-01-24       Impact factor: 5.182

Review 7.  Nanotechnology for neuronal ion channels.

Authors:  F Lehmann-Horn; K Jurkat-Rott
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-11       Impact factor: 10.154

Review 8.  Voltage-gated sodium channels at 60: structure, function and pathophysiology.

Authors:  William A Catterall
Journal:  J Physiol       Date:  2012-04-02       Impact factor: 5.182

9.  Effect of sensor domain mutations on the properties of voltage-gated ion channels: molecular dynamics studies of the potassium channel Kv1.2.

Authors:  Lucie Delemotte; Werner Treptow; Michael L Klein; Mounir Tarek
Journal:  Biophys J       Date:  2010-11-03       Impact factor: 4.033

Review 10.  CFTR structure and function: is there a role in the kidney?

Authors:  J Souza-Menezes; M M Morales
Journal:  Biophys Rev       Date:  2009-01-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.